[Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
The authors share their experience about the application of the NovoSeven in four cases with different types of hemostasiologic disturbances. The possibilities for its use in obstetrics and gynecology are discussed.
Pekhlivanov
B
B
Milchev
N
N
Abrashev
B
B
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects; D036861:Delivery, Obstetric; D005168:Factor VII Deficiency / Q000097:blood / Q000188:drug therapy*; D015942:Factor VIIa / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006473:Postpartum Hemorrhage / Q000517:prevention & control*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
D011994:Recombinant Proteins; D015942:Factor VIIa